168 related articles for article (PubMed ID: 20337495)
1. 2-MeS-beta,gamma-CCl2-ATP is a potent agent for reducing intraocular pressure.
Eliahu S; Martín-Gil A; Perez de Lara MJ; Pintor J; Camden J; Weisman GA; Lecka J; Sévigny J; Fischer B
J Med Chem; 2010 Apr; 53(8):3305-19. PubMed ID: 20337495
[TBL] [Abstract][Full Text] [Related]
2. Identification of hydrolytically stable and selective P2Y(1) receptor agonists.
Eliahu SE; Camden J; Lecka J; Weisman GA; Sévigny J; Gélinas S; Fischer B
Eur J Med Chem; 2009 Apr; 44(4):1525-36. PubMed ID: 18760862
[TBL] [Abstract][Full Text] [Related]
3. Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists.
Ravi RG; Kim HS; Servos J; Zimmermann H; Lee K; Maddileti S; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 May; 45(10):2090-100. PubMed ID: 11985476
[TBL] [Abstract][Full Text] [Related]
4. A novel insulin secretagogue based on a dinucleoside polyphosphate scaffold.
Eliahu S; Barr HM; Camden J; Weisman GA; Fischer B
J Med Chem; 2010 Mar; 53(6):2472-81. PubMed ID: 20175517
[TBL] [Abstract][Full Text] [Related]
5. Adenosine 5'-O-(1-boranotriphosphate) derivatives as novel P2Y(1) receptor agonists.
Nahum V; Zündorf G; Lévesque SA; Beaudoin AR; Reiser G; Fischer B
J Med Chem; 2002 Nov; 45(24):5384-96. PubMed ID: 12431066
[TBL] [Abstract][Full Text] [Related]
6. Adenine nucleotide effect on intraocular pressure: Involvement of the parasympathetic nervous system.
Peral A; Gallar J; Pintor J
Exp Eye Res; 2009 Jun; 89(1):63-70. PubMed ID: 19250934
[TBL] [Abstract][Full Text] [Related]
7. Sp-2-propylthio-ATP-α-B and Sp-2-propylthio-ATP-α-B,β-γ-dichloromethylene are novel potent and specific agonists of the human P2Y₁₁ receptor.
Haas M; Ben-Moshe I; Fischer B; Reiser G
Biochem Pharmacol; 2013 Sep; 86(5):645-55. PubMed ID: 23810430
[TBL] [Abstract][Full Text] [Related]
8. Diadenosine and diuridine poly(borano)phosphate analogues: synthesis, chemical and enzymatic stability, and activity at P2Y1 and P2Y2 receptors.
Nahum V; Tulapurkar M; Lévesque SA; Sévigny J; Reiser G; Fischer B
J Med Chem; 2006 Mar; 49(6):1980-90. PubMed ID: 16539385
[TBL] [Abstract][Full Text] [Related]
9. Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffold.
Nadel Y; Lecka J; Gilad Y; Ben-David G; Förster D; Reiser G; Kenigsberg S; Camden J; Weisman GA; Senderowitz H; Sévigny J; Fischer B
J Med Chem; 2014 Jun; 57(11):4677-91. PubMed ID: 24846781
[TBL] [Abstract][Full Text] [Related]
10. Novel modified adenosine 5'-triphosphate analogues pharmacologically characterized in human embryonic kidney 293 cells highly expressing rat brain P2Y(1) receptor: Biotinylated analogue potentially suitable for specific P2Y(1) receptor isolation.
Zündorf G; Schäfer R; Vöhringer C; Halbfinger E; Fischer B; Reiser G
Biochem Pharmacol; 2001 May; 61(10):1259-69. PubMed ID: 11322930
[TBL] [Abstract][Full Text] [Related]
11. Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.
Horiuchi T; Dietrich HH; Hongo K; Dacey RG
Stroke; 2003 Jun; 34(6):1473-8. PubMed ID: 12730558
[TBL] [Abstract][Full Text] [Related]
12. Are P2Y1 purinoceptors expressed in turkey erythrocytes?
Sak K
Neurosci Lett; 2000 Oct; 293(1):78-80. PubMed ID: 11065143
[TBL] [Abstract][Full Text] [Related]
13. A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist.
Jacob TF; Singh V; Dixit M; Ginsburg-Shmuel T; Fonseca B; Pintor J; Youdim MBH; Major DT; Weinreb O; Fischer B
Purinergic Signal; 2018 Sep; 14(3):271-284. PubMed ID: 30019187
[TBL] [Abstract][Full Text] [Related]
14. Adenine triphosphate nucleotides are antagonists at the P2Y receptor.
Kauffenstein G; Hechler B; Cazenave JP; Gachet C
J Thromb Haemost; 2004 Nov; 2(11):1980-8. PubMed ID: 15550030
[TBL] [Abstract][Full Text] [Related]
15. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
[TBL] [Abstract][Full Text] [Related]
16. ATP analogues with modified phosphate chains and their selectivity for rat P2X2 and P2X2/3 receptors.
Spelta V; Mekhalfia A; Rejman D; Thompson M; Blackburn GM; North RA
Br J Pharmacol; 2003 Nov; 140(6):1027-34. PubMed ID: 14581175
[TBL] [Abstract][Full Text] [Related]
17. P2 receptor agonists stimulate insulin release from human pancreatic islets.
Fernandez-Alvarez J; Hillaire-Buys D; Loubatières-Mariani MM; Gomis R; Petit P
Pancreas; 2001 Jan; 22(1):69-71. PubMed ID: 11138974
[TBL] [Abstract][Full Text] [Related]
18. Hydrolysis of P2-purinoceptor agonists by a purified ectonucleotidase from the bovine aorta, the ATP-diphosphohydrolase.
Picher M; Sévigny J; D'Orléans-Juste P; Beaudoin AR
Biochem Pharmacol; 1996 Jun; 51(11):1453-60. PubMed ID: 8630086
[TBL] [Abstract][Full Text] [Related]
19. Direct excitation of inhibitory interneurons by extracellular ATP mediated by P2Y1 receptors in the hippocampal slice.
Kawamura M; Gachet C; Inoue K; Kato F
J Neurosci; 2004 Dec; 24(48):10835-45. PubMed ID: 15574734
[TBL] [Abstract][Full Text] [Related]
20. Agonist action of adenosine triphosphates at the human P2Y1 receptor.
Palmer RK; Boyer JL; Schachter JB; Nicholas RA; Harden TK
Mol Pharmacol; 1998 Dec; 54(6):1118-23. PubMed ID: 9855642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
